Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 3 Next Page Last Page
 
1
Summary Basis of Approval: Hepatitis C Virus Encoded ...

Page 1. ABBOTT PRISMHCV Summary of Basis for Approval Product Trade Name(s) ABBOTT PRISMHCV Proper ...

Center for Biologics Evaluation and Research (CBER)

2
July 11, 2007 Approval Letter - Abbott PRISM HCV

... July 11, 2007. Our STN: BL 103762/0. Abbott Laboratories Attention: Susan Sanborn D-49C, AP6C/2 100 Abbott Park Road Chicago, IL 60064. Dear Ms. Sanborn: ...

Center for Biologics Evaluation and Research (CBER)

3
ABBOTT PRISM HBcore

... ABBOTT PRISM HBcore. Proper Name: Hepatitis B Virus Core Antigen (E.coli, Recombinant) Tradename: ABBOTT PRISM HBcore Manufacturer ...

Center for Biologics Evaluation and Research (CBER)

4
PRODUCT CORRECTION: ABBOTT PRISM Reaction Trays

... time (DT) error codes when using ABBOTT PRISM HBsAg (List Number 06D19) and ABBOTT PRISM HIV O Plus (List Number 03L68) assays and the ABBOTT PRISM Reaction ...

Center for Biologics Evaluation and Research (CBER)

5
Abbott Prism Positive Run Control Kit - label

Page 1. 1 ABBOTT PRISM� Positive Run Control Kit List No. 3E60-11 34-3827/R7 ABBOTT PRISM Positive Run Control Kit Customer Service ...

Center for Biologics Evaluation and Research (CBER)

6
ABBOTT PRISM HBsAg; ABBOTT PRISM HBsAg Confirmatory

... Proper Name: Antibody to Hepatitis B Surface Antigen (Mouse Monoclonal IgM); Antibody to Hepatitis B Surface Antigen (Human) Tradename: ABBOTT PRISM HBsAg ...

Center for Biologics Evaluation and Research (CBER)

7
Abbott Prism Run Control Kit - label

Page 1. ABBOTT PRISM Run Control Kit 1 ABBOTT LABORATORIES List No. 3E60-10 Diagnostics Division Printed in USA Abbott Park, Illinois 60064 ...

Center for Biologics Evaluation and Research (CBER)

8
ABBOTT PRISM HTLV-I/HTLV-II

The ABBOTT PRISM HTLV-I/HTLV-II assay is an in vitro chemiluminescent immunoassay (ChLIA) for the qualitative detection of antibodies to ...

Center for Biologics Evaluation and Research (CBER)

9
April 30, 2010 Approval Letter - Abbott Prism Chagas

... Our STN: BL 125361/0 Abbott Laboratories Attention: Ms. Susan Sanborn Diagnostics Division, D-49C/AP6C-2 100 Abbott Park Road Abbott Park, IL 60064-6092. ...

Center for Biologics Evaluation and Research (CBER)

10
Recall of Abbott Prism HIV O Plus

... REASON: Abbott has seen an increase in customer complaints for calibration failures when PRISM-HIV-1 Group O Positive Assay Control (2) (Symbol: OPC) is out of ...

Center for Biologics Evaluation and Research (CBER)

11
July 18, 2006 Approval Letter - ABBOTT PRISM HBsAg; ABBOTT PRISM ...

... We have approved your biologics license application for Antibody to Hepatitis B Surface Antigen (Mouse Monoclonal IgM) and Antibody to Hepatitis B Surface ...

Center for Biologics Evaluation and Research (CBER)

12
[Distribution of hepatitis C virus genotypes in Manisa region, Turkey].
2009-10-01

The duration of hepatitis C virus (HCV) infection and the response to the standard therapy is strongly related to the HCV genotypes. In addition, the geographical distribution of HCV genotypes is important for the epidemiological studies in terms of distribution and possible risk groups. The aim of this retrospective study was to ...

PubMed

13
Label - Hepatitis C Virus Encoded Antigen - Abbott HCV EIA ...

... 3. Avoid microbial contamination of specimens, reagents and water used for washing. ... be shipped ambient, refrigerated (2 to 8�C) on wet ice, or ...

Center for Biologics Evaluation and Research (CBER)

14
Abbott Prism Positive Run Control Kit - label

... Customer Service United States: 1-877-4ABBOTT ... in accordance with local, state, and federal regulations.7,8 ... BIBLIOGRAPHY 1. US Department of Labor, Occupational ...

Center for Biologics Evaluation and Research (CBER)

15
September 18, 2009 Approval Letter - ABBOTT PRISM HIV O ...

... BLA) for Human Immunodeficiency Virus Types 1 and 2 (E. coli, B. megaterium, Recombinant) Antigen and Synthetic Peptide effective this date. ...

Center for Biologics Evaluation and Research (CBER)

16
Hepatitis C Virus Encoded Antigens (Recombinant c100-3 ...

... signal is generated by addition of an alkaline hydrogen peroxide solution. ... to the ABBOTT PRISM Operations Manual, Section 3. REAGENTS NOTE ...

Center for Biologics Evaluation and Research (CBER)

17
Antibody to Hepatitis B Surface Antigen (Mouse Monoclonal ...

... by your firm as well as the one found on your website for the ABBOTT PRISM HBcore promote the indication, sample types, reactivity and sensitivity ...

Center for Biologics Evaluation and Research (CBER)

18
Antibody to Hepatitis B Surface Antigen (Human); ABBOTT PRISM ...

... These azides may explode upon percussion, such as hammering. ... Solutions required for instrument cleaning and maintenance are described in detail in the ...

Center for Biologics Evaluation and Research (CBER)

19
Abbott Prism Run Control Kit - label

... Sodium azide has been reported to form lead or copper azide in laboratory plumbing. These azides may explode upon percussion, such as hammering. ...

Center for Biologics Evaluation and Research (CBER)

20
Abbott Prism Chagas

... Resources for You. Trypanosoma cruzi (T. cruzi) (Anti-T. cruzi Assay); Testing HCT/P Donors for Relevant Communicable Disease Agents and Diseases. -. ...

Center for Biologics Evaluation and Research (CBER)

First Page Previous Page 1 2 3 Next Page Last Page
 
First Page Previous Page 1 2 3 Next Page Last Page
 
21
ABBOTT PRISM HTLV-I/HTLV-II Package Insert

... Avoid microbial and chemical contamination of samples, reagents, and equipment. ... Hjelle B, Mills R, Swenson S, et al. ...

Center for Biologics Evaluation and Research (CBER)

22
Multicenter evaluation of a fully automated third-generation anti-HCV antibody screening test with excellent sensitivity and specificity.
2010-09-24

Early detection of hepatitis C virus (HCV) is an important step in preventing progression to cirrhosis and hepatocellular carcinoma. Serologic assays for anti-hepatitis C (anti-HCV) antibody are valuable first-line tests in the screening and diagnosis of HCV infection. The aim of this multicenter study was to compare the Elecsys(�) ...

PubMed

23
Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for the clinical usefulness of confirming anti-HCV results.
2011-09-21

HCV is a global healthcare problem. Diagnosis of HCV infection is mainly based on the detection of anti-HCV antibodies as a screening test on sera samples. Recombinant immunoblot assays are used as supplemental tests and in the final detection and quantification of HCV RNA in confirmatory tests. In this study, we ...

PubMed

24
BioLife Plasma Services Experience with HBV NAT Testing

... Genetic Systems TM. 5,435,228, 27, 1 in 232,451. Abbott PRISM TM. 10,222,462, 8, 1 in 1,277,808. Abbott PRISM has reduced the NAT only yield by 5.5-fold. 5. ...

Center for Biologics Evaluation and Research (CBER)

25
Label - Hepatitis C Virus Encoded Antigen - Abbott HCV EIA 2.0

... of the Positive and Negative Controls (PN) must ... Assay Inter-Assay Inter-Lot Control N OD ... II. Experimental transmission, putative virus agents and markers, and ...

Center for Biologics Evaluation and Research (CBER)

26
January 16, 2008 Approval Letter - ABBOTT PRISM HTLV-1/HTLV-II

... of release from the Director, Center for Biologics Evaluation and Research (CBER). ... testing, packaging or labeling of Human T-Lymphotropic Virus Types I and II ...

Center for Biologics Evaluation and Research (CBER)

27
Hepatitis B Virus Core Antigen (E.coli, Recombinant) ABBOTT PRISM ...

... No. PLA# 98-0297 and ELA# 98-0365) ... off the blood cell, on the blood cell and on ... triglycerides, bilirubin, hemoglobin, protein and red blood cells), 4) assay ...

Center for Biologics Evaluation and Research (CBER)

28
ABBOTT PRISM@ HBsAg

... Confinnatory, BL 103766 Ver 1.1 Page 3. d. 3 Bottles (l0.4 mL each) Positive Calibrator (Human). Recalcified, inactivated plasma ...

Center for Biologics Evaluation and Research (CBER)

29
ABBOTT PRISM HTLV-I/HTLV-II Package Insert

... Virus Types I and II ... in specific immunoassays.65,66 Tests based on reactivities to HTLV-I and HTLV-II type specific proteins may enable viral typing. ...

Center for Biologics Evaluation and Research (CBER)

30
ABBOTT PRISM HIV O Plus

... For the detection of antibodies to HIV-1 (anti-HIV-1) Groups M and O and/or antibodies to HIV-2 (anti-HIV-2) in human serum and plasma ...

Center for Biologics Evaluation and Research (CBER)

31
An in vitro system combined with an in-house quantitation assay for screening hepatitis C virus inhibitors.
2003-05-01

Hepatitis C virus (HCV) infection is a serious global health problem. Interferon-alpha (IFN-alpha) and ribavirin have demonstrated efficacy in the treatment of HCV infection; however, these therapies display many side effects. To screen the anti-HCV compounds from plants, we established an in vitro model for inoculation of ...

PubMed

32
Novel Evolved Immunoglobulin (Ig)-Binding Molecules Enhance the Detection of IgM against Hepatitis C Virus
2011-04-14

Detection of specific antibodies against hepatitis C virus (HCV) is the most widely available test for viral diagnosis and monitoring of HCV infections. However, narrowing the serologic window of anti-HCV detection by enhancing anti-HCV IgM detection has remained to be a problem. Herein, we used LD5, a novel ...

PubMed Central

33
Clinical evaluation of the signal-to-cutoff ratios of hepatitis C virus antibody screening tests used in China.
2011-11-01

The clinical diagnosis of hepatitis C virus (HCV) infection is important to direct an accurate course of therapy. Previous studies have reported a correlation between the signal-to-cutoff (S/CO) ratios of the anti-HCV screening test and confirm HCV infections for American anti-HCV screening kits as well as for ...

PubMed

34
Hepatitis C markers in hemodialysis patients.
1993-07-01

The prevalence of hepatitis C virus (HCV) infection among the patients of a hemodialysis unit in Taiwan was determined by an immunoblot and reverse transcriptase-polymerase chain reaction algorithm to be 58.8% (67 of 114 patients) after serological surveys with two advanced-generation enzyme-linked immunosorbent assays (ELISAs) for anti-HCV and a C 100-3 ...

PubMed Central

35
Antibody dynamics and spontaneous viral clearance in patients with acute hepatitis C infection in Rio de Janeiro, Brazil
2011-01-12

BackgroundThe anti-HCV antibody response has not been well characterized during the early phase of HCV infection and little is known about its relationship to the clinical course during this period.MethodsWe analyzed serial anti-HCV antibodies longitudinally obtained from a prospective cohort of 65 patients with acute ...

PubMed Central

36
Generation and characterization of chimeric antibodies against NS3, NS4, NS5, and core antigens of hepatitis C virus.
2010-04-28

Mouse-human chimeric antibodies (cAbs) against hepatitis C virus (HCV) core, NS3 (nonstructural), NS4, and NS5 antigens were developed as quality control (QC) reagents to replace the use of human sera/plasma for Abbott HCV immunoassays. The cAb retains the mouse monoclonal antibody (MAb) specificity and affinity but still reacts in the ...

PubMed

37
Generation and Characterization of Chimeric Antibodies against NS3, NS4, NS5, and Core Antigens of Hepatitis C Virus ?
2010-06-28

Mouse-human chimeric antibodies (cAbs) against hepatitis C virus (HCV) core, NS3 (nonstructural), NS4, and NS5 antigens were developed as quality control (QC) reagents to replace the use of human sera/plasma for Abbott HCV immunoassays. The cAb retains the mouse monoclonal antibody (MAb) specificity and affinity but still reacts in the ...

PubMed Central

38
Improving clinical laboratory efficiency: a time-motion evaluation of the Abbott m2000 RealTime and Roche COBAS AmpliPrep/COBAS TaqMan PCR systems for the simultaneous quantitation of HIV-1 RNA and HCV RNA.
2011-05-28

Abstract Background: Diagnostic laboratories need automation that facilitates efficient processing and workflow management to meet today's challenges for expanding services and reducing cost, yet maintaining the highest levels of quality. Methods: Processing efficiency of two commercially available automated systems for quantifying HIV-1 and HCV RNA, ...

PubMed

39
[Measurement of hepatitis C virus RNA 12 weeks after treatment predicts sustained virological response in HIV-HCV co-infected patients.
2011-09-01

OBJECTIVE: The aim of this study was to assess whether measurement of hepatitis C virus RNA (HCV-RNA) at 12 weeks post-treatment could predict sustained virological response (SVR) to antiviral therapy for chronic hepatitis C (pegylated interferon alfa-2a and ribavirin) in HIV-co-infected patients. PATIENTS AND METHODS: HIV-HCV co-infected patients were ...

PubMed

40
Seroprevalence of hepatitis B and hepatitis C markers among children and adolescents in the south Brazilian region: metropolitan area of Florian�polis, Santa Catarina.

Hepatitis B and C are important causes of morbidity and mortality worldwide. In Brazil, according to the Ministry of Health, about 15% of population is infected by hepatitis B virus (HBV) and less than 1% by hepatitis C virus (HCV). Nevertheless, the age-specific prevalence of HBV and HCV markers remains unknown. This study aimed to determine the ...

PubMed

First Page Previous Page 1 2 3 Next Page Last Page
 
First Page Previous Page 1 2 3 Next Page Last Page
 
41
Hepatitis C virus infection at Sharkia Governorate, Egypt: seroprevalence and associated risk factors.
2004-04-01

Because many persons with chronic hepatitis C virus (HCV) infection are asymptomatic, population based serologic studies are needed to estimate the prevalence of infection and to develop and evaluate prevention efforts. A sample of 1422 individuals was included in the study by using multistage sampling technique. Their age ranged from 4-78 years with a mean age (34.7 +/- ...

PubMed

First Page Previous Page 1 2 3 Next Page Last Page